Last week saw the Dow recover a goodly portion of the previous week’s loss. The move higher resulted in a change at the top as Merck & Co. Inc. (NYSE: MRK) replaced Apple Inc. (NASDAQ: AAPL) as the Dow’s top performer in 2018. Merck shares added about 2.7% last week to give the pharmaceutical giant a year-to-date gain of 28.4%.
The second-best performer among the Dow index equities so far this year is Microsoft Corp. (NASDAQ: MSFT), up 24.1% followed by Apple, up 22.6%; Visa Inc. (NYSE: V), also up 22.6%; and Nike Inc. (NYSE: NKE), up 22.4%. Of the 30 Dow stocks, 19 have managed to post gains to date in 2018.
The blue-chip index shed more than 580 points last week to close at 25,270.83, up about 2.4% compared to the previous Friday’s close. For the year to date, the index is up 1.8%, trailing the Nasdaq Composite (5%) but leading the S&P 500 (up about 1%).
The primary reason that Merck displaced Apple as the Dow’s top performer last week was Apple’s lackluster Thursday earnings report. The tech giant dropped 6.6% on Friday to close the week down 4%. At the same time, Merck added 2.7%.
The drugmaker got some good news on Tuesday when the U.S. Food and Drug Administration approved its Keytruda lung cancer drug in combination with two other drugs for first-line treatment of patients with metastatic squamous non-small cell lung cancer.
Merck’s shares closed Friday at $72.27, down about 1.2% for the day, in a 52-week range of $52.83 to $74.49. The consensus price target is $79.12 and the company’s forward price-earnings ratio is 15.34.
24/7 Wall St.Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
